Header Logo

Connection

MARINA KONOPLEVA to Drug Monitoring

Back to Details
This is a "connection" page, showing publications MARINA KONOPLEVA has written about Drug Monitoring.
MARINA KONOPLEVA
Connection Strength
0.105
Drug Monitoring
  1. A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia. Clin Cancer Res. 2015 Jun 15; 21(12):2704-14.
    View in: PubMed
    Score: 0.105
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.